Anju Sreelatha - Publications

University of Texas Southwestern Medical Center, Dallas, TX, United States 

11/11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sreelatha A, Nolan C, Park BC, Pawłowski K, Tomchick DR, Tagliabracci VS. A effector kinase is activated by host inositol hexakisphosphate. The Journal of Biological Chemistry. PMID 32229585 DOI: 10.1074/Jbc.Ra120.013067  0.36
2019 Lopez VA, Park BC, Nowak D, Sreelatha A, Zembek P, Fernandez J, Servage KA, Gradowski M, Hennig J, Tomchick DR, Pawłowski K, Krzymowska M, Tagliabracci VS. A Bacterial Effector Mimics a Host HSP90 Client to Undermine Immunity. Cell. PMID 31522888 DOI: 10.1016/J.Cell.2019.08.020  0.36
2018 Sreelatha A, Yee SS, Lopez VA, Park BC, Kinch LN, Pilch S, Servage KA, Zhang J, Jiou J, Karasiewicz-Urbańska M, Łobocka M, Grishin NV, Orth K, Kucharczyk R, Pawłowski K, et al. Protein AMPylation by an Evolutionarily Conserved Pseudokinase. Cell. PMID 30270044 DOI: 10.1016/J.Cell.2018.08.046  0.52
2016 Nguyen KB, Sreelatha A, Durrant ES, Lopez-Garrido J, Muszewska A, Dudkiewicz M, Grynberg M, Yee S, Pogliano K, Tomchick DR, Pawłowski K, Dixon JE, Tagliabracci VS. Phosphorylation of spore coat proteins by a family of atypical protein kinases. Proceedings of the National Academy of Sciences of the United States of America. PMID 27185916 DOI: 10.1073/Pnas.1605917113  0.52
2015 Sreelatha A, Kinch LN, Tagliabracci VS. The secretory pathway kinases. Biochimica Et Biophysica Acta. 1854: 1687-93. PMID 25862977 DOI: 10.1016/J.Bbapap.2015.03.015  0.52
2015 Sreelatha A, Bennett TL, Carpinone EM, O'Brien KM, Jordan KD, Burdette DL, Orth K, Starai VJ. Vibrio effector protein VopQ inhibits fusion of V-ATPase-containing membranes. Proceedings of the National Academy of Sciences of the United States of America. 112: 100-5. PMID 25453092 DOI: 10.1073/pnas.1413764111  0.52
2014 Lewallen DM, Sreelatha A, Dharmarajan V, Madoux F, Chase P, Griffin PR, Orth K, Hodder P, Thompson PR. Inhibiting AMPylation: a novel screen to identify the first small molecule inhibitors of protein AMPylation. Acs Chemical Biology. 9: 433-42. PMID 24274060 DOI: 10.1021/Cb4006886  0.52
2013 Sreelatha A, Orth K, Starai VJ. The pore-forming bacterial effector, VopQ, halts autophagic turnover. Autophagy. 9: 2169-70. PMID 24145145 DOI: 10.4161/auto.26449  0.52
2013 Sreelatha A, Bennett TL, Zheng H, Jiang QX, Orth K, Starai VJ. Vibrio effector protein, VopQ, forms a lysosomal gated channel that disrupts host ion homeostasis and autophagic flux. Proceedings of the National Academy of Sciences of the United States of America. 110: 11559-64. PMID 23798441 DOI: 10.1073/pnas.1307032110  0.52
2013 Muñoz E, Sreelatha A, Garriga R, Baughman RH, Goux WJ. Amyloidogenic peptide/single-walled carbon nanotube composites based on tau-protein-related peptides derived from AcPHF6: preparation and dispersive properties. The Journal of Physical Chemistry. B. 117: 7593-604. PMID 23745842 DOI: 10.1021/Jp402057D  0.52
2011 Ham H, Sreelatha A, Orth K. Manipulation of host membranes by bacterial effectors Nature Reviews Microbiology. 9: 635-646. PMID 21765451 DOI: 10.1038/nrmicro2602  0.52
Hide low-probability matches.